(Q37037132)

17 August 2017

1 reference

title

Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers (English)

1 reference

17 August 2017

0 references

Stephen Yip

1

1 reference

PubMed ID

18091559

17 August 2017

A John Iafrate

series ordinal

2

1 reference

PubMed ID

18091559

17 August 2017

David N Louis

series ordinal

3

1 reference

17 August 2017

1 January 2008

1 reference

Journal of Neuropathology & Experimental Neurology

17 August 2017

1 reference

17 August 2017

67

1 reference

17 August 2017

1

1 reference

17 August 2017

1-15

1 reference

Biomarkers in cancer staging, prognosis and treatment selection

17 August 2017

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Molecular markers for diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Prognostic and predictive markers in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Prognostic and predictive factors revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

The biology of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Experts wrestle with problems developing biomarkers, search for new tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

The application of microarray technology to neuropathology: cutting edge tool with clinical diagnostics potential or too much information?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

The molecular epidemiology of gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Correlations between molecular profile and radiologic pattern in oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Reclassification of oligoastrocytomas by loss of heterozygosity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Single nucleotide polymorphism array analysis of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Oligodendroglioma: impact of molecular biology on its definition, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Survey of treatment recommendations for anaplastic oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

MGMT methylation: a marker of response to temozolomide in low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Downregulation of RUNX3 and TES by hypermethylation in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Gastrointestinal stromal tumors: imatinib and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Lung cancer: intragenic ERBB2 kinase mutations in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

New approaches to molecular cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

The molecular and genetic basis of neurological tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Targeted molecular therapy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

PTEN: from pathology to biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Phase II trial of gefitinib in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

Changing paradigms--an update on the multidisciplinary management of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31815F65FB

10.1097/NEN.0B013E31815F65FB

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18091559